832 related articles for article (PubMed ID: 17456796)
1. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
[TBL] [Abstract][Full Text] [Related]
2. Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression.
Zhao LY; Xu JY; Shi Z; Englert NA; Zhang SY
Biochem Pharmacol; 2017 Oct; 142():194-203. PubMed ID: 28756207
[TBL] [Abstract][Full Text] [Related]
3. Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes.
Post SM; de Wit EC; Princen HM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3064-70. PubMed ID: 9409294
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
[TBL] [Abstract][Full Text] [Related]
5. Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene.
Gnerre C; Blättler S; Kaufmann MR; Looser R; Meyer UA
Pharmacogenetics; 2004 Oct; 14(10):635-45. PubMed ID: 15454728
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
7. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
[TBL] [Abstract][Full Text] [Related]
8. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene.
Owsley E; Chiang JY
Biochem Biophys Res Commun; 2003 Apr; 304(1):191-5. PubMed ID: 12705905
[TBL] [Abstract][Full Text] [Related]
9. Antiatherosclerotic effect of farnesoid X receptor.
Mencarelli A; Renga B; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
[TBL] [Abstract][Full Text] [Related]
10. Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids.
Handschin C; Gnerre C; Fraser DJ; Martinez-Jimenez C; Jover R; Meyer UA
Arch Biochem Biophys; 2005 Feb; 434(1):75-85. PubMed ID: 15629111
[TBL] [Abstract][Full Text] [Related]
11. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
12. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
Bramlett KS; Yao S; Burris TP
Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
[TBL] [Abstract][Full Text] [Related]
13. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
[TBL] [Abstract][Full Text] [Related]
14. FXR-mediated down-regulation of CYP7A1 dominates LXRalpha in long-term cholesterol-fed NZW rabbits.
Xu G; Li H; Pan LX; Shang Q; Honda A; Ananthanarayanan M; Erickson SK; Shneider BL; Shefer S; Bollineni J; Forman BM; Matsuzaki Y; Suchy FJ; Tint GS; Salen G
J Lipid Res; 2003 Oct; 44(10):1956-62. PubMed ID: 12897188
[TBL] [Abstract][Full Text] [Related]
15. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Hirayama T; Tint GS; Doy M; Shefer S
J Lipid Res; 2005 Feb; 46(2):287-96. PubMed ID: 15576845
[TBL] [Abstract][Full Text] [Related]
16. Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism.
Bhalla S; Ozalp C; Fang S; Xiang L; Kemper JK
J Biol Chem; 2004 Oct; 279(43):45139-47. PubMed ID: 15322103
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
Inagaki T; Choi M; Moschetta A; Peng L; Cummins CL; McDonald JG; Luo G; Jones SA; Goodwin B; Richardson JA; Gerard RD; Repa JJ; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2005 Oct; 2(4):217-25. PubMed ID: 16213224
[TBL] [Abstract][Full Text] [Related]
18. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts.
He J; Nishida S; Xu M; Makishima M; Xie W
Gastroenterology; 2011 Jun; 140(7):2095-106. PubMed ID: 21354151
[TBL] [Abstract][Full Text] [Related]
19. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
[TBL] [Abstract][Full Text] [Related]
20. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor.
Goodwin B; Gauthier KC; Umetani M; Watson MA; Lochansky MI; Collins JL; Leitersdorf E; Mangelsdorf DJ; Kliewer SA; Repa JJ
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):223-8. PubMed ID: 12509506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
